AzurRx BioPharma - Corporate Governance

SEARCH

About
Science & Technology
- - Back
  - Products
    
    Back
    
    MS-1819
    
    FW-420
    
    FW-1022
  - Programs
    
    Back
    
    Pipeline
    
    Clinical Trials
  - Indications
    
    Back
    
    EPI in Cystic Fibrosis
    
    Checkpoint Inhibitor Colitis
    
    COVID-19 GI Infection
Investors
- - Back
  - Press Releases
    
    Back
    
    2021
    
    2020
    
    2019
    
    2018
    
    2017
    
    2016
    
    2015
    
    2014
  - Events
  - Presentations
  - Regulatory Filings
  - Financial Statements
  - Stock Info
  - Analyst Coverage
  - Corporate Governance
  - Contact Us
News & Publications
- - Back
  - Press Releases
  - Interviews
    
    Back
    
    2021
    
    2020
  - Clinical Publications
Contact
- - Back
  - Contact Us
  - Subscribe
  - Partnering

facebook
twitter
linkedin
youtube

Home
Investors
Corporate Governance

Menu

Press Releases
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Events
Presentations
Regulatory Filings
Financial Statements
Stock Info
Analyst Coverage
Corporate Governance
Contact Us

Corporate Governance

Corporate Governance and Nominating Committee Charter

Compensation Committee Charter

Audit Committee Charter

About
Science & Technology
Investors
News & Publications
Contact

Contact Us

AzurRx BioPharma, Inc.

777 Yamato Road
Suite 502
Boca Raton, FL 33431

Tel: (561) 589-7020
info@azurrx.com

AzurRx SAS

Jardin des Entreprises, Bat 1
290, Chemin de Saint-Dionisy
30980 Langlade, France

Tel: +33 (0)4 66 67 08 16